| 1. | EXECUTIVE SUMMARY | 
| 1.1. | Glossary of terms | 
| 1.2. | Colors of biotechnology | 
| 1.3. | What is white biotechnology? | 
| 1.4. | White Biotechnology 2024-2034: scope | 
| 1.5. | Trends and drivers in white biotechnology | 
| 1.6. | Synthetic biology as applied to white biotechnology | 
| 1.7. | Technology trends in white biotechnology | 
| 1.8. | Overview of alternative feedstocks for white biotechnology | 
| 1.9. | Major market challenges for white biotechnology | 
| 1.10. | Technical challenges facing white biotechnology | 
| 1.11. | Products derived from white biotechnology: overview | 
| 1.12. | Molecules that can be produced through industrial biomanufacturing | 
| 1.13. | Molecules that can be produced through industrial biomanufacturing | 
| 1.14. | Company landscape in white biotechnology | 
| 1.15. | Company landscape in white biotechnology | 
| 1.16. | Next-generation fuels through white biotechnology | 
| 1.17. | Bioplastics through white biotechnology | 
| 1.18. | Navigating biobased polymers from monosaccharides | 
| 1.19. | Common bioplastics and polymer precursors synthesized via white biotechnology | 
| 1.20. | Status of molecules produced through white biotechnology | 
| 1.21. | White biotechnology market share by molecule 2024-2034 | 
| 1.22. | White biotechnology global capacity forecast 2024-2034 | 
| 1.23. | White biotechnology global capacity forecast 2024-2034: discussion | 
| 1.24. | Emerging areas of white biotechnology forecast 2024-2034 | 
| 1.25. | Company profiles | 
| 2. | INTRODUCTION | 
| 2.1. | Glossary of acronyms | 
| 2.2. | Glossary of terms | 
| 2.3. | Colors of biotechnology | 
| 2.4. | What is white biotechnology? | 
| 2.5. | The bioeconomy and white biotechnology | 
| 2.6. | Report focus | 
| 3. | MARKET ANALYSIS | 
| 3.1. | Market Drivers for White Biotechnology | 
| 3.1.1. | Market drivers: demand for biobased products | 
| 3.1.2. | Market drivers: government regulation on petroleum-based plastic use | 
| 3.1.3. | Market drivers: government support of biotechnology | 
| 3.1.4. | Market drivers: carbon taxes | 
| 3.2. | Economic Viability of White Biotechnology | 
| 3.2.1. | Factors affecting the economic viability of white biotechnology projects | 
| 3.2.2. | Effects of Brent crude prices on biobased products | 
| 3.2.3. | The Green Premium | 
| 3.2.4. | Rising feedstock prices | 
| 3.2.5. | Effect of cell factory on cost | 
| 3.2.6. | Identifying the chemicals with the most potential to become biobased based on price | 
| 3.2.7. | How scale-up affects cost | 
| 3.2.8. | Zymergen: case study on economics of synthetic biology | 
| 3.2.9. | Synthetic biology: shift from commodity products to lower volume, high value markets | 
| 3.2.10. | Major market challenges for white biotechnology | 
| 3.3. | Player and Start-up Landscape | 
| 3.3.1. | Players: synthetic biology tools and platforms | 
| 3.3.2. | Players: vertically integrated biomanufacturing | 
| 3.3.3. | Emerging players segmented by molecule | 
| 3.3.4. | Overview of chemicals and materials companies involved in white biotechnology | 
| 4. | CELL FACTORIES FOR WHITE BIOTECHNOLOGY | 
| 4.1. | Cell factories for biomanufacturing: factors to consider | 
| 4.2. | Cell factories for biomanufacturing: a range of organisms | 
| 4.3. | Escherichia coli (E.coli) | 
| 4.4. | Corynebacterium glutamicum (C. glutamicum) | 
| 4.5. | Bacillus subtilis (B. subtilis) | 
| 4.6. | Saccharomyces cerevisiae (S. cerevisiae) | 
| 4.7. | Yarrowia lipolytica (Y. lipolytica) | 
| 4.8. | Microorganisms used in different biomanufacturing processes | 
| 4.9. | Non-model organisms for white biotechnology | 
| 5. | TECHNOLOGY DEVELOPMENTS | 
| 5.1. | Synthetic Biology | 
| 5.1.1. | Synthetic biology: the design and engineering of biological systems | 
| 5.1.2. | Synthetic biology: manipulating the central dogma | 
| 5.1.3. | The vast scope of synthetic biology | 
| 5.1.4. | The Process of Synthetic Biology: Design, Build and Test | 
| 5.1.5. | Synthetic biology: why now? | 
| 5.1.6. | Synthetic biology: from pharmaceuticals to consumer products | 
| 5.1.7. | Synthetic biology: disrupting existing supply chains | 
| 5.1.8. | Synthetic biology: drivers and barriers for adoption | 
| 5.1.9. | Synthetic biology as applied to white biotechnology | 
| 5.2. | Tools and Techniques of Synthetic Biology | 
| 5.2.1. | Tools and techniques of synthetic biology: overview | 
| 5.2.2. | DNA Synthesis | 
| 5.2.3. | Introduction to CRISPR-Cas9 | 
| 5.2.4. | CRISPR-Cas9: a bacterial immune system | 
| 5.2.5. | CRISPR-Cas9's importance to synthetic biology | 
| 5.2.6. | Protein/Enzyme Engineering | 
| 5.2.7. | Computer-Aided Design | 
| 5.2.8. | Commercial examples of engineered proteins in industrial applications | 
| 5.2.9. | Strain construction and optimization | 
| 5.2.10. | Synergy between synthetic biology and  metabolic engineering | 
| 5.2.11. | Framework for developing industrial microbial strains | 
| 5.2.12. | The problem with scale | 
| 5.2.13. | Introduction to cell-free systems | 
| 5.2.14. | Cell-free versus cell-based systems | 
| 5.2.15. | Cell-free systems in the context of white biotechnology | 
| 5.2.16. | Cell-free systems for white biotechnology | 
| 5.2.17. | Commercial implementation of cell-free systems: Solugen | 
| 5.2.18. | Startups pursuing cell-free systems for white biotechnology | 
| 5.2.19. | Robotics: enabling hands-free and high throughput science | 
| 5.2.20. | Robotic cloud laboratories | 
| 5.2.21. | Automating organism design and closing the loop | 
| 5.2.22. | Artificial intelligence and machine learning | 
| 5.3. | Improvement of Biomanufacturing Processes | 
| 5.3.1. | Continuous vs batch biomanufacturing | 
| 5.3.2. | Benefits and challenges of continuous biomanufacturing | 
| 5.3.3. | Continuous vs batch biomanufacturing: key fermentation parameter comparison | 
| 5.3.4. | Machine learning to improve biomanufacturing processes | 
| 5.4. | White Biotechnology for Sustainability | 
| 5.4.1. | White biotechnology as a sustainable technology | 
| 5.4.2. | Routes for carbon capture in white biotechnology | 
| 5.4.3. | Autotrophic bacteria for carbon capture through biomanufacturing | 
| 5.5. | Alternative Feedstocks for Biomanufacturing | 
| 5.5.1. | Why use alternative feedstocks for white biotechnology? | 
| 5.5.2. | Food, land, and water competition | 
| 5.5.3. | C1 feedstocks: metabolic pathways | 
| 5.5.4. | C1 feedstocks: economic benefits | 
| 5.5.5. | C1 feedstocks: challenges | 
| 5.5.6. | Non-methane C1 feedstocks | 
| 5.5.7. | C1 feedstocks: products | 
| 5.5.8. | C1 feedstocks: gas fermentation | 
| 5.5.9. | C2 feedstocks | 
| 5.5.10. | C2 feedstocks: products segmented by feedstock | 
| 5.5.11. | C1 and C2 feedstocks: commercial activity | 
| 5.5.12. | C1 and C2 feedstocks: commercial activity | 
| 5.5.13. | Lignocellulosic biomass feedstocks | 
| 5.5.14. | Lignocellulosic biomass feedstocks: challenges | 
| 5.5.15. | Lignocellulosic biomass feedstocks: products | 
| 5.5.16. | Lignocellulosic feedstocks: commercial activity | 
| 6. | BLUE BIOTECHNOLOGY | 
| 6.1. | What is blue biotechnology? | 
| 6.2. | Main biocatalysts of blue biotechnology: cyanobacteria and algae | 
| 6.3. | Cyanobacteria | 
| 6.4. | Algae | 
| 6.5. | Key drivers and challenges for blue biotechnology | 
| 6.6. | Selected startups in blue biotechnology | 
| 7. | PRODUCTS DERIVED FROM WHITE BIOTECHNOLOGY | 
| 7.1. | Overview | 
| 7.1.1. | Products derived from white biotechnology: overview | 
| 7.2. | Fuels | 
| 7.2.1. | Biofuels made from white biotechnology | 
| 7.2.2. | Metabolic pathways to biofuels | 
| 7.2.3. | Bioethanol | 
| 7.2.4. | Next-generation bioethanol | 
| 7.2.5. | Next-generation ethanol - operational plants | 
| 7.2.6. | Next-generation ethanol - operational plants | 
| 7.2.7. | Next-generation ethanol - planned plants | 
| 7.2.8. | Next-generation ethanol - non-operational and cancelled plants | 
| 7.2.9. | Diesel from biomanufacturing pathways | 
| 7.2.10. | Farnesene | 
| 7.2.11. | n-Butanol | 
| 7.2.12. | Isobutanol | 
| 7.2.13. | Methanol | 
| 7.2.14. | Blue biotechnology in biofuel production | 
| 7.2.15. | Blue biotechnology in biodiesel production | 
| 7.2.16. | Blue biotechnology in bioethanol production | 
| 7.2.17. | Blue biotechnology for biofuel production: key challenges for commercial viability | 
| 7.2.18. | Blue biotechnology for biofuel production: commercial activity by US oil producers | 
| 7.2.19. | Blue biotechnology for biofuel production: commercial activity by non-US oil producers | 
| 7.2.20. | Blue biotechnology for biofuel production: list of current and former players | 
| 7.2.21. | Blue biotechnology for biofuel production: list of current and former players | 
| 7.2.22. | Blue biotechnology for biofuel production: list of current and former players | 
| 7.3. | Plastics and Textiles | 
| 7.3.1. | Introduction to bioplastics | 
| 7.3.2. | Production of bioplastics through white biotechnology | 
| 7.3.3. | Navigating biobased polymers from monosaccharides | 
| 7.3.4. | Common bioplastics and bioplastic precursors synthesized via white biotechnology | 
| 7.3.5. | Lactic Acid and Polylactic Acid (PLA) | 
| 7.3.6. | Molecules for Other Biobased Synthetic Polyesters | 
| 7.3.7. | Molecules for Other Biobased Synthetic Polymers | 
| 7.3.8. | Naturally Occurring Biobased Polymers: Polyhydroxyalkanoates (PHAs) | 
| 7.3.9. | Other Textiles Produced through White Biotechnology | 
| 7.4. | Other Chemicals, Precursors, and Additives | 
| 7.4.1. | Acetone | 
| 7.4.2. | Acrylic acid | 
| 7.4.3. | Itaconic acid | 
| 7.4.4. | Biobased ethanol as a precursor | 
| 7.4.5. | Biomanufacturing of ethylene | 
| 7.4.6. | Monoethylene glycol (MEG) | 
| 7.4.7. | Biobased MEG: monomer production | 
| 7.4.8. | Biobased MEG: industry landscape | 
| 7.4.9. | Polyethylene terephthalate (PET) | 
| 7.4.10. | Biobased polyolefins | 
| 7.4.11. | Braskem: "I'm green" polyethylene | 
| 7.4.12. | Biomanufacturing of propylene precursors | 
| 7.4.13. | Malonic acid | 
| 7.4.14. | Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs) | 
| 7.4.15. | Short chain fatty acids: acetic acid | 
| 7.4.16. | Triglycerides | 
| 7.4.17. | Other organic acids and aldehydes | 
| 7.4.18. | Bacterial cellulose | 
| 7.5. | Other Products Derived from White Biotechnology | 
| 7.5.1. | Overview of vitamins and amino acids produced through white biotechnology | 
| 7.5.2. | Overview of white biotechnology for cosmetics | 
| 7.5.3. | Biomanufacturing for surfactants and detergents | 
| 7.5.4. | Enzymes for onward use: Novozymes | 
| 7.5.5. | Cement alternatives from biomanufacturing: BioMason | 
| 7.5.6. | Precision fermentation: definition and scope | 
| 8. | FORECASTS FOR WHITE BIOTECHNOLOGY | 
| 8.1. | Forecast methodology | 
| 8.2. | White biotechnology market share by molecule 2024-2034 | 
| 8.3. | White biotechnology global capacity forecast 2024-2034 | 
| 8.4. | White biotechnology global capacity forecast 2024-2034: discussion | 
| 8.5. | White biotechnology global capacity forecast 2024-2034: discussion | 
| 8.6. | Emerging areas of white biotechnology forecast 2024-2034 | 
| 8.7. | Emerging areas of white biotechnology forecast: discussion | 
| 9. | COMPANY PROFILES | 
| 9.1. | Arzeda | 
| 9.2. | Bolt Threads | 
| 9.3. | CinderBio | 
| 9.4. | Danimer Scientific | 
| 9.5. | Ecovative | 
| 9.6. | Kraig Biocraft Laboratories | 
| 9.7. | LanzaTech | 
| 9.8. | Mango Materials | 
| 9.9. | Metabolic Explorer | 
| 9.10. | Modern Meadow | 
| 9.11. | Natureworks | 
| 9.12. | Newlight Technologies | 
| 9.13. | Novozymes | 
| 9.14. | Spiber | 
| 9.15. | Succinity | 
| 9.16. | Total Corbion | 
| 10. | APPENDIX | 
| 10.1. | White biotechnology global capacity forecast 2024-2034 | 
| 10.2. | Emerging areas of white biotechnology forecast 2024-2034 |